Fenchem has announced that it will launch a new product, SAMe-way(TM) SAM-e (S-adenosyl-methionine) targeting the US mood product market.
SAM-e (S-adenosyl-methionine) is a prescription medication in European countries, used to treat depression and joint pain, but is sold as a supplement in the U.S, where annual sales are close to $100 million in 2007. This market is expected to expand.
SAM-way(TM) is available in two forms of Ademetionine 1,4-Butanedisulfonate and Ademetionine Disulfate Tosylate.
Fenchem will officially launch the product at the coming events of FIC and IFT.
Fenchem is a science-based company specialized in developing and manufacturing natural ingredients for
nutritional supplements. With a professional R&D team and traceable Q/C system, Fenchem provides
creative ingredients with high bio-activity and safety to meet your unique demands.